Once again the Hi-tech and Electronics sector provided the Overall Winner for this year’s European Supply Chain Excellence Awards. Infineon Technologies deservedly took the top trophy having returned to the competition this year with renewed vigour to com
Browsing: Logistics & Supply Chain
FMCG is always one of the hardest-fought categories in the Awards, and this year was no exception.
As the British public reel from the tragic news of the loss of four brave firefighters who died in a warehouse fire at a fruit and vegetable packing plant in Atherstone, Warwicks, at the weekend, questions relating to safety procedures and documentation o
We arrived with four finalists in what, we must admit, is a bit of a ”mish-mash” of a category, but is essentially the engineering industries and their supply bases. None the less, the assessors believe they have identified a worthy winner.
The bestLog project, initiated by the European Commission, is making great progress on its way to establishing its core objective – an exchange platform for the improvement of sustainable supply chain management practice across Europe.
The Healthcare category produced four shortlisted finalists, although for reasons that are obscure, one fancied entry didn”t continue through the assessment procedure.
Teamwork can mean almost anything – who hasn”t been baffled by a job application asking you to ”demonstrate teamwork”? It”s safe to say though that any organisation making it onto the shortlist of finalists in these Awards must be displaying teamwork
The Outstanding Contribution category of the European Supply Chain Excellence Awards is very different from all the others: you, our readers, nominate the candidates, and you vote by email for the winner (and none of those shenanigans that other less repu
Pundits and politicians talk about the need for joined-up thinking, and ERP vendors and systems integrators are equally enthisiastic. But just how joined-up are our supply chains in reality?
Bringing new drugs to market is a very expensive business: typically it can cost over €500 million and – given time limitations on patents – the pharmaceuticals company then has just 5-10 years or so to recoup its investment and make a profit for most the
